Skip to main content
. 2005 Aug 18;5:103. doi: 10.1186/1471-2407-5-103

Figure 1.

Figure 1

Cytotoxicity of rituximab and gemcitabine. WSU-FSCCL or DoHH2 cells incubated with varying concentrations of gemcitabine, and 4 hr later ± 20 μg/ml rituximab. Cytotoxicity is expressed as percentage of untreated control cells at 72 hr.